• Contact us
  • Advertise with us
  • Login
Tashi Pharma
  • Home
  • Indian Pharma News
  • Global Pharma News
  • Guideline News
    • All
    • EDQM
    • EMA
    • European Commision
    • Health Canada
    • Medsafe
    • MHRA
    • SAHPRA
    • US FDA
    FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments

    FDA publishes Clinical Trial Guidances for Advancing Development of Cancer Treatments

    Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C

    US FDA publishes guidance on Initiation of Voluntary Recalls

    EMA publishes Q & A for Bootstrap methodology for f2 similarity factor

    EMA publishes Q & A on Bootstrap methodology for f2 similarity factor

    US FDA publishes product-specific guidances to facilitate generic drug development

    US FDA publishes product-specific guidances to facilitate generic drug development

    Clinical Trials Regulation comes into effect in the EU

    New Clinical Trials Regulation comes into effect in the EU

    Reflection paper Forecasting demand for medicinal products in the EU_EEA

    EMA publishes reflection paper on forecasting demand for medicinal products in the EU/EEA

    Trending Tags

    • Pharma
    • EMA
    • MHRA
    • TGA
    • US FDA
  • Articles
  • Interview
  • Company Focus
  • Pharma Jobs
    • Quality
    • Regulatory Affairs
    • Production
    • Sales and Marketing
    • Clinical
    • bioanalytical
  • Webinar
No Result
View All Result
  • Home
  • Indian Pharma News
  • Global Pharma News
  • Guideline News
    • All
    • EDQM
    • EMA
    • European Commision
    • Health Canada
    • Medsafe
    • MHRA
    • SAHPRA
    • US FDA
    FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments

    FDA publishes Clinical Trial Guidances for Advancing Development of Cancer Treatments

    Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C

    US FDA publishes guidance on Initiation of Voluntary Recalls

    EMA publishes Q & A for Bootstrap methodology for f2 similarity factor

    EMA publishes Q & A on Bootstrap methodology for f2 similarity factor

    US FDA publishes product-specific guidances to facilitate generic drug development

    US FDA publishes product-specific guidances to facilitate generic drug development

    Clinical Trials Regulation comes into effect in the EU

    New Clinical Trials Regulation comes into effect in the EU

    Reflection paper Forecasting demand for medicinal products in the EU_EEA

    EMA publishes reflection paper on forecasting demand for medicinal products in the EU/EEA

    Trending Tags

    • Pharma
    • EMA
    • MHRA
    • TGA
    • US FDA
  • Articles
  • Interview
  • Company Focus
  • Pharma Jobs
    • Quality
    • Regulatory Affairs
    • Production
    • Sales and Marketing
    • Clinical
    • bioanalytical
  • Webinar
No Result
View All Result
No Result
View All Result
Home Interview

Pharmaceutical Entrepreneur Who Began Early…..

Arjun Deshpande, CEO & Founder of Generic Aadhar, one of India's fastest growing retail pharmacy chain. In this interview, Arjun Deshpande speaks about his entrepreneurial journey & vision for his company

PRN by PRN
April 10, 2021
in Interview
275 15
0
Pharmaceutical Entrepreneur Who Began Early…..
187
SHARES
446
VIEWS

How did the idea of entrepreneurship evolve in your mind at the age of 16 ?

Arjun Deshpande: I saw the actual problem at very young age of 14 -15yrs that time I use to travel different Countries… I observed the real issue and wanted to change the entire pharma traditional system. So, it strikes me in 2017 and I worked out the solution that there should a change in the working pattern of the same old tradition of Pharma Industry. Hence That was the Time, I emerged as an Entrepreneur in 2018 and created Entrepreneurs across India through my innovative idea of “Generic Aadhaar”. Generic Aadhaar is the NEW ERA in the Pharma World and Honor to be Titled as “Pharma Wonder Kid” by Forbes India. I am hear to solving the main issue which was a long traditional in Pharma Industry. Also, it was the need of an hour for such Change for Goodness.

What was the idea behind Generic Aadhaar ?

Arjun Deshpande: It was all clear to Support the Common Man’s Monthly Medicine Budget and to backed the Single Retailer Stores was the innovatory idea. Generic Aadhaar is on a mission to provide affordable and accessible Generic Medicines to the underprivileged people of India. We are on a vision to make India better in Health Sector and also, we are providing Job Opportunities across India in this panic Pandemic Situation…

How is Generic Aadhaar helping the patients who need medicines ?

Arjun Deshpande: Generic Aadhaar are helping and supporting many different category patients i.e from Cardiology, Hypertension, Gastrology, Neurology, Nephrology etc. we have expanded in 130+ cities in India and have our stores across nation, hence there are many senior pension holder citizens who give blessing as they get their daily medicines at very affordable rate. Thus, some patients mail us WhatsApp us or share the required medicine through various mediums and we help them out through stores address and sometimes via Couriers. Also, we have Launched the GENERIC AADHAAR APP recently where anyone can download it for free and can check the nearby our Store Locations for the medicines.

Your company has received investments from Mr. Ratan Tata. How is his guidance/advice helping in your business?

Arjun Deshpande: Yes, it was the turning point for me and a Kick Start to get Ratan Sir’s backed support for my startup venture Generic Aadhaar. He is Truly inspiring the Millions of People not only in India but he is a Global ICON and I am blessed to have a mentor like him who supports and guide me for my best and I am proud that we are on Same Mission for providing better healthcare treatments for the Masses. Our pharma company is now rapidly growing pharma company of India with its Operations in 130+ cities not only tier 1 but also in tier 2 and tier 3 cities, as I believe actual India starts from 30kms – 40kms away from Metro cities in interior states across India. We get calls and emails and messages from pan India for franchise stores initiatives or for medicines thus it indicates we have reached the Maximum people in India, Still I feel there is long way to grow and go.

How does Generic Aadhaar help Pharmacists/Chemists to increase their business ?

Arjun Deshpande: On a survey or statistics there are 10Lakhs + Stand Alone Pharmacy in India who suffers huge competitions in Pharma Sector so for giving them full back support and making them survive in the heavy competitional world we are here to make them stronger in their particular areas by providing them our brand value name and supporting their store and family. I have created Revolution in the Pharma Industry. We are Creating Entrepreneurs across India and whoever getting associated with us are happy because their customers the End Consumers are Happy… As they are Saving up to 80-90% on their monthly medicine Bills. Most of the Senior Citizens who are also the Pension Holders request our Franchise stores to provide home deliveries as well as it’s a panic covid 19 pandemic Pandemic Situation and yes, our Frontline workers are fully geared and they are helping those needy patients at times. If the Company is supporting and Helping the Common man of India then definitely the company grow and also the business and People who are associated with it.

What is your vision for the company?

Arjun Deshpande: My vision and Mission were very focused and clear that to bring all small medical stores under one roof of our Brand Generic Aadhaar to help them and to support their business grow with huge profits. Generic Aadhaar is assisting the stand-alone pharmacy to compete with big retail medical malls and online pharmacy as well to provide highest discount on Life Saving Medicines. We are expanding to give the Best Solution for the daily issues of Common Man who are facing the problems of unnecessary high prices on Medicines which affects the “AAM JANTA”.

Where do you want to see Generic Aadhaar after 10 years ?

Arjun Deshpande: In each corner of India mostly in rural India for helping those underprivileged people. I want to see Generic Aadhaar to be each homes Aadhaar on Medicines requirements.

What advice do you want to give to young entrepreneurs ?

Arjun Deshpande: Observe…Research…Plan…Process and be unique and always work on Solution based models it will help you reach another level of peak. I will advise same generation or coming ones always be organized and value the Time Ideas which strikes you. Maybe it will work slowly to execute but will be impactful. Always have Positive Attitude towards your idea or Dream. Put all your efforts and Hard work with Smart work to build an empire of your own also be grounded if you reach a peak, because being grounded make you reach ultimate in this Competitive World. Be Different Be Unique and Create Revolution in any field you wish to grow. Never quitting is one thing but TRYING is all above the Major Aspect of Living.

Tags: Pharma NewspharmacyPharmareg NewsRatan Tata
Previous Post

NIH COVID-19 Treatment Guidelines Strongly Recommend Use of REGEN-COV™ (casirivimab with imdevimab) in Outpatients at High Risk of Clinical Progression

Next Post

Biocon Pharma Limited receives GMP compliance certificate from MHRA, UK

PRN

PRN

Related Posts

How UK is providing large investment opportunity for life sciences sector
Interview

How UK is providing large investment opportunity for life sciences sector

by PRN
May 30, 2021
In this Interview, Milan Patel narrates his journey with Troikaa pharmaceuticals, passion for innovation, upcoming exciting developments and guidance for pharmacy students & young entrepreneurs.
Interview

An Entrepreneur Known for Innovations…..

by PRN
May 16, 2021
Mr Ramiz Nathani, Co-Founder & COO of Researcher
Interview

An Entrepreneur who is a Researcher as well…..

by PRN
May 16, 2021
An Entrepreneur who is digitizing the Pharmaceutical Manufacturing…….
Interview

An Entrepreneur who is digitizing the Pharmaceutical Manufacturing…….

by PRN
May 8, 2021
An Entrepreneur who started at different location……….
Interview

An Entrepreneur who started at different location……….

by PRN
April 24, 2021
Next Post

Biocon Pharma Limited receives GMP compliance certificate from MHRA, UK

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent News

Zydus to launch Oxemia

Zydus to launch Oxemia (Desidustat) a treatment for Anemia in patients with Chronic Kidney Disease (CKD)

March 7, 2022
FDA Urges Companies to be 'Recall Ready’ to Protect Public Health as Part of Final Guidance for Voluntary Recalls

US FDA Urges Companies to be ’Recall Ready’ to Protect Public Health

March 6, 2022
FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments

FDA publishes Clinical Trial Guidances for Advancing Development of Cancer Treatments

March 5, 2022
Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C

US FDA publishes guidance on Initiation of Voluntary Recalls

March 5, 2022
Kilitch Drugs Commences Rs. 100 Crore New Facility Expansion Plan

Kilitch Drugs Commences Rs. 100 Crore New Facility Expansion Plan

March 5, 2022

Browse by Category

  • Articles
  • Company Focus
  • EDQM
  • EMA
  • European Commision
  • Global Pharma News
  • Guideline News
  • Health Canada
  • Indian Pharma News
  • Interview
  • Medsafe
  • MHRA
  • SAHPRA
  • US FDA
  • Webinar

Browse by Tags

Abbott Alembic alkem Amgen Amneal AstraZeneca bayer biocon Biogen BioNTech Bristol Myers Squibb cipla covid Daiichi Sankyo drreddy Eli Lilly fda Gilead glenmark gsk Incyte Janssen Jubilant lupin MHRA Moderna Natco Novartis Novavax novo nordisk oncology Panacea Biotech Pfizer pharmacy Pharma News Pharmareg News Remdesivir roche sanofi Sun pharma Teva usfda Vaccine Viatris zydus

Contact us

Address:Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002.
Phone:+91 8511586232, +91 9029066605
Email:author@pharmaregnews.com

Browse by Tag

Abbott Alembic alkem Amgen Amneal AstraZeneca bayer biocon Biogen BioNTech Bristol Myers Squibb cipla covid Daiichi Sankyo drreddy Eli Lilly fda Gilead glenmark gsk Incyte Janssen Jubilant lupin MHRA Moderna Natco Novartis Novavax novo nordisk oncology Panacea Biotech Pfizer pharmacy Pharma News Pharmareg News Remdesivir roche sanofi Sun pharma Teva usfda Vaccine Viatris zydus

Advertise with us

© 2021 - Pharmaregnews.com. Developed by YESWEUS.

No Result
View All Result
  • Home
  • Indian Pharma News
  • Global Pharma News
  • Guideline News
    • EMA
    • MHRA
    • TGA
    • US FDA
  • Articles
  • Interview
  • Company Focus
  • Pharma Jobs
    • Quality
    • Regulatory Affairs
    • Production
    • Sales and Marketing
    • bioanalytical
    • Clinical
  • Webinar
  • Contact us
  • Advertise with us
  • Login

© 2021 - Pharmaregnews.com. Developed by YESWEUS.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?